IRIS Accounts Production v23.3.1.45 01010652 Board of Directors 1.5.22 30.4.23 30.4.23 false true false false false true false Fair value model iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh010106522022-04-30010106522023-04-30010106522022-05-012023-04-30010106522021-04-30010106522021-05-012022-04-30010106522022-04-3001010652ns10:Originalns15:EnglandWales2022-05-012023-04-3001010652ns14:PoundSterlingns10:Original2022-05-012023-04-3001010652ns10:Originalns10:Director12022-05-012023-04-3001010652ns10:Original2022-05-012023-04-3001010652ns10:Original2023-04-3001010652ns10:Originalns10:PrivateLimitedCompanyLtd2022-05-012023-04-3001010652ns10:Originalns10:SmallEntities2022-05-012023-04-3001010652ns10:Originalns10:AuditExempt-NoAccountantsReport2022-05-012023-04-3001010652ns10:Originalns10:SmallCompaniesRegimeForDirectorsReport2022-05-012023-04-3001010652ns10:SmallCompaniesRegimeForAccountsns10:Original2022-05-012023-04-3001010652ns10:Originalns10:FullAccounts2022-05-012023-04-3001010652ns10:Original12022-05-012023-04-3001010652ns10:Originalns10:Director22022-05-012023-04-3001010652ns10:Originalns10:RegisteredOffice2022-05-012023-04-3001010652ns10:Original2022-04-3001010652ns10:Originalns5:CurrentFinancialInstruments2023-04-3001010652ns10:Originalns5:CurrentFinancialInstruments2022-04-3001010652ns10:Originalns5:Non-currentFinancialInstruments2023-04-3001010652ns10:Originalns5:Non-currentFinancialInstruments2022-04-3001010652ns5:ShareCapitalns10:Original2023-04-3001010652ns5:ShareCapitalns10:Original2022-04-3001010652ns10:Originalns5:CapitalRedemptionReserve2023-04-3001010652ns10:Originalns5:CapitalRedemptionReserve2022-04-3001010652ns10:Originalns5:FurtherSpecificReserve3ComponentTotalEquity2023-04-3001010652ns10:Originalns5:FurtherSpecificReserve3ComponentTotalEquity2022-04-3001010652ns10:Originalns5:RetainedEarningsAccumulatedLosses2023-04-3001010652ns10:Originalns5:RetainedEarningsAccumulatedLosses2022-04-3001010652ns10:Originalns5:NetGoodwill2022-05-012023-04-3001010652ns5:IntangibleAssetsOtherThanGoodwillns10:Original2022-05-012023-04-3001010652ns10:Originalns5:LandBuildings2022-05-012023-04-3001010652ns10:Originalns5:PlantMachinery2022-05-012023-04-3001010652ns10:Original2021-05-012022-04-3001010652ns10:Originalns5:NetGoodwill2022-04-3001010652ns10:Originalns5:NetGoodwill2023-04-3001010652ns10:Originalns5:NetGoodwill2022-04-3001010652ns10:Originalns5:LandBuildings2022-04-3001010652ns10:Originalns5:PlantMachinery2022-04-3001010652ns10:Original2022-04-3001010652ns10:Originalns5:LandBuildings2023-04-3001010652ns10:Originalns5:PlantMachinery2023-04-3001010652ns10:Originalns5:LandBuildings2022-04-3001010652ns10:Originalns5:PlantMachinery2022-04-3001010652ns10:Originalns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-04-3001010652ns10:Originalns5:CurrentFinancialInstrumentsns5:WithinOneYear2022-04-3001010652ns10:Originalns5:FurtherSpecificReserve3ComponentTotalEquity2022-04-30
REGISTERED NUMBER: 01010652 (England and Wales)















UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 APRIL 2023

FOR

TEMPLE PHARMACY LIMITED

TEMPLE PHARMACY LIMITED (REGISTERED NUMBER: 01010652)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 APRIL 2023




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


TEMPLE PHARMACY LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 30 APRIL 2023







DIRECTORS: Mr S J Patel
Mrs S S Martel





REGISTERED OFFICE: 6 The Slade
London
SE18 2NB





REGISTERED NUMBER: 01010652 (England and Wales)





ACCOUNTANTS: Bayar Hughes & Co
Chartered Certified Accountants
4 Green Lane Business Park
238 Green lane
New Eltham
London
SE9 3TL

TEMPLE PHARMACY LIMITED (REGISTERED NUMBER: 01010652)

BALANCE SHEET
30 APRIL 2023

2023 2022
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 2 2
Tangible assets 5 323,473 347,758
323,475 347,760

CURRENT ASSETS
Stocks 144,855 150,579
Debtors 6 437,387 458,478
Cash at bank and in hand 220,678 257,689
802,920 866,746
CREDITORS
Amounts falling due within one year 7 342,248 417,941
NET CURRENT ASSETS 460,672 448,805
TOTAL ASSETS LESS CURRENT
LIABILITIES

784,147

796,565

CREDITORS
Amounts falling due after more than one
year

8

-

(13,784

)

PROVISIONS FOR LIABILITIES (9,500 ) (9,500 )
NET ASSETS 774,647 773,281

CAPITAL AND RESERVES
Called up share capital 50,000 50,000
Capital redemption reserve 57 57
Fair value reserve 9 255,753 255,753
Retained earnings 468,837 467,471
SHAREHOLDERS' FUNDS 774,647 773,281

TEMPLE PHARMACY LIMITED (REGISTERED NUMBER: 01010652)

BALANCE SHEET - continued
30 APRIL 2023


The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 April 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 April 2023 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 9 October 2023 and were signed on its behalf by:





Mr S J Patel - Director


TEMPLE PHARMACY LIMITED (REGISTERED NUMBER: 01010652)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 APRIL 2023

1. STATUTORY INFORMATION

Temple Pharmacy Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts.

Goodwill
Goodwill, being the amount paid in connection with the acquisition of a business in 1984, is being amortised evenly over its estimated useful life of twenty years.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Land and buildings - 5% on reducing balance and not provided
Plant and machinery etc - 25% on reducing balance and 15% on reducing balance

Investment property
Investment property are shown at most recent valuation. Any aggregate surplus or deficit arising from changes in fair value is recognised in profit or loss.

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

TEMPLE PHARMACY LIMITED (REGISTERED NUMBER: 01010652)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 APRIL 2023

2. ACCOUNTING POLICIES - continued

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 23 (2022 - 25 ) .

4. INTANGIBLE FIXED ASSETS
Goodwill
£   
COST
At 1 May 2022
and 30 April 2023 68,000
AMORTISATION
At 1 May 2022
and 30 April 2023 67,998
NET BOOK VALUE
At 30 April 2023 2
At 30 April 2022 2

5. TANGIBLE FIXED ASSETS
Plant and
Land and machinery
buildings etc Totals
£    £    £   
COST
At 1 May 2022
and 30 April 2023 360,887 521,376 882,263
DEPRECIATION
At 1 May 2022 115,964 418,541 534,505
Charge for year 7,960 16,325 24,285
At 30 April 2023 123,924 434,866 558,790
NET BOOK VALUE
At 30 April 2023 236,963 86,510 323,473
At 30 April 2022 244,923 102,835 347,758

6. DEBTORS
2023 2022
£    £   
Amounts falling due within one year:
Trade debtors 170,067 173,978
Other debtors 2,820 -
172,887 173,978

TEMPLE PHARMACY LIMITED (REGISTERED NUMBER: 01010652)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 APRIL 2023

6. DEBTORS - continued
2023 2022
£    £   
Amounts falling due after more than one year:
Amount Due by Associated Company 264,500 284,500

Aggregate amounts 437,387 458,478

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Trade creditors 329,099 399,190
Taxation and social security 5,997 12,056
Other creditors 7,152 6,695
342,248 417,941

8. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
2023 2022
£    £   
Other creditors - 13,784

9. RESERVES
Fair
value
reserve
£   
At 1 May 2022
and 30 April 2023 255,753

10. AMOUNT DUE BY ASSOCIATED COMPANY (NOTE 8)

The £264,500 is owed by 'Temple Investment Holdings Limited'. This sum represents as interest free loan over an indefinite time period, which will certainly exceed 25 years.